TrialHeadache2026

OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trial.

Andrew M Blumenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.